Dabigatran Sandoz 110 mg

Dabigatran Sandoz 110 mg is a medicine authorised by Swissmedic under authorisation number 68658. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 June 2023 and the authorisation is limited until 06 June 2028. ATC code B01AE07 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 68658
  • ATC B01AE07
  • Synthetic medicines
Authorisation data
Authorisation number68658
NameDabigatran Sandoz 110 mg
Full nameDabigatran Sandoz 110 mg, Hartkapseln
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB01AE07
First authorisation07 June 2023
Authorisation validity06 June 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Dabigatran Sandoz 110 mg, HartkapselnB07 June 2023
2Dabigatran Sandoz 150 mg, HartkapselnB07 June 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
160Kapsel(n)B01AE0706.03.0.B
2180Kapsel(n)B01AE0706.03.0.B
360Kapsel(n)B01AE0706.03.0.B
4180Kapsel(n)B01AE0706.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Dabigatran Sandoz 110 mg authorised in Switzerland?

Yes. Dabigatran Sandoz 110 mg is authorised by Swissmedic under authorisation number 68658, data as of 01 September 2026. The authorisation is limited until 06 June 2028.

Which dispensing category does Dabigatran Sandoz 110 mg have?

Dabigatran Sandoz 110 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Dabigatran Sandoz 110 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com